CIK 0002096997 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Kailera Therapeutics, Inc.
Sign in to watch- Ticker
- KLRA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 508-440-9475
- Business address
- 180 THIRD AVENUE, 4TH FLOOR, WALTHAM, MA, 02451
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-04-20 | RTW INVESTMENTS, LP 10% owner | Purchase | +500,000 | $16.00 | $8.0M | 10,776,820 |
| 2026-04-20 | BAIN CAPITAL INVESTORS LLC 10% owner | Purchase | +8,398,438 | $16.00 | $134.4M | 26,255,581 |
| 2026-04-20 | Koppel Adam Director | Purchase | +1,562,500 | $16.00 | $25.0M | 22,583,268 |
| 2026-04-20 | Bain Capital Life Sciences Investors, LLC 10% owner | Purchase | +1,562,500 | $16.00 | $25.0M | 22,583,268 |
| 2026-04-20 | Kaplan Andrew T. Director | Purchase | +8,398,438 | $16.00 | $134.4M | 26,255,581 |
Page 1 of 1 · 5 trades